Information Provided By: 
Fly News Breaks for August 3, 2018
NUS
Aug 3, 2018 | 07:37 EDT
As previously reported, Stifel analyst Mark Astrachan upgraded Nu Skin to Hold from Sell as he believes the valuation discount to its direct selling peers is likely to narrow given the improving momentum evident in its Q2 results. Improving sales leader and customers, which have historically been leading indicators of sales trends, suggests to Astrachan that the company's current 2018 sales guidance could be conservative, he added. He raised his price target on Nu Skin shares to $70 from $57.
News For NUS From the Last 2 Days
There are no results for your query NUS
